Is NAIL a Good ETF to Buy?
If you’re thinking about buying the NAIL ETF, this article…
Sell
44
PATH Quote, Financials, Valuation and Earnings
Last price:
$13.35
Seasonality move
:
-7.03%
Day range:
$13.66 - $14.59
52-week range:
$10.37 - $27.87
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.52x
P/B ratio:
4.38x
Volume:
17.1M
Avg. volume:
10.4M
1-year change:
-38.92%
Market cap:
$7.6B
Revenue:
$1.3B
EPS (TTM):
-$0.16
Analysts' Opinion
-
Consensus RatingUiPath has received a consensus rating of Hold. The company's average rating is a Hold based on 2 Buy ratings, 20 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $15.73, UiPath has an estimated upside of 13.88% from its current price of $13.81.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $13.00 representing 100% downside risk from its current price of $13.81.
Fair Value
-
According to the consensus of 23 analysts, UiPath has 13.88% upside to fair value with a price target of $15.73 per share.
PATH vs. S&P 500
-
Over the past 5 trading days, UiPath has overperformed the S&P 500 by 5.54% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
UiPath does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
UiPath has grown year-over-year revenues for 0 quarters straight. In the most recent quarter UiPath reported revenues of $354.7M.
Earnings Growth
-
UiPath has grown year-over-year earnings for 0 quarters straight. In the most recent quarter UiPath reported earnings per share of -$0.02.
Enterprise value:
6B
EV / Invested capital:
3.48x
Price / LTM sales:
5.52x
EV / EBIT:
--
EV / Revenue:
4.27x
PEG ratio (5yr expected):
--
EV / Free cash flow:
19.50x
Price / Operating cash flow:
25.23x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$1.2B
Return On Assets:
-3.28%
Net Income Margin (TTM):
-6.49%
Return On Equity:
-4.78%
Return On Invested Capital:
-4.78%
Operating Margin:
-12.23%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2023-10-31 | 2024-10-31 | |
| Income Statement | ||||||
| Revenue | $1B | $1.2B | $1.4B | $325.9M | $354.7M | |
| Gross Profit | $866.2M | $1B | $1.2B | $276M | $290.9M | |
| Operating Income | -$354M | -$225M | -$181.1M | -$55.8M | -$43.4M | |
| EBITDA | -$332.5M | -$208.4M | -$161M | -$50.4M | -$38.8M | |
| Diluted EPS | -$0.67 | -$0.28 | -$0.16 | -$0.06 | -$0.02 | |
| Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $2.2B | $2.2B | $2.4B | $2.2B | |
| Total Assets | -- | $2.5B | $2.5B | $2.8B | $2.7B | |
| Current Liabilities | -- | $467.3M | $476.6M | $627.7M | $695.5M | |
| Total Liabilities | -- | $584.3M | $651.9M | $825.8M | $931.4M | |
| Total Equity | -- | $1.9B | $1.9B | $2B | $1.7B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2023-10-31 | 2024-10-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$110M | $247.4M | $320.1M | $41.9M | $28.1M | |
| Cash From Investing | -$169M | -$557.4M | -$37.4M | -$60.3M | -$22.9M | |
| Cash From Financing | -$46.2M | -$131.9M | -$515.4M | -$69.2M | -$172.6M | |
| Free Cash Flow | -$134.7M | $241.7M | $308.8M | $41.2M | $23.2M | |
PATH
Sector
Market Cap
$7.6B
$128.7M
Price % of 52-Week High
49.55%
69.94%
Dividend Yield
0%
0%
Shareholder Yield
6.35%
0.91%
1-Year Price Total Return
-38.92%
-2.33%
Beta (5-Year)
--
0.919
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$13.08
200-day SMA
Sell
Level
$14.54
Bollinger Bands (100)
Buy
Level
12.1 - 13.78
Chaikin Money Flow
Buy
Level
28.2M
20-day SMA
Buy
Level
$13.63
Relative Strength Index (RSI14)
Buy
Level
54.44
ADX Line
Buy
Level
26.04
Williams %R
Neutral
Level
-36.9668
50-day SMA
Buy
Level
$13.45
MACD (12, 26)
Sell
Level
-0.17
25-day Aroon Oscillator
Sell
Level
-56
On Balance Volume
Neutral
Level
97M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (8.4729)
Buy
CA Score
(Annual)
Level (0.3346)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-0.1899)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
UiPath offers an end-to-end cross-application enterprise automation platform. The platform leverages a range of automation technologies including robotic process automation, application programming interface, and artificial intelligence. UiPath’s solution can automate a broad range of repetitive tasks across industries including claims processing, employee onboarding, invoice to cash, loan applications, and customer service.
Stock Forecast FAQ
In the current month, PATH has received 2 Buy ratings 20 Hold ratings, and 1 Sell ratings. The PATH average analyst price target in the past 3 months is $15.73.
-
Where Will UiPath Stock Be In 1 Year?
According to analysts, the consensus estimate is that UiPath share price will rise to $15.73 per share over the next 12 months.
-
What Do Analysts Say About UiPath?
Analysts are divided on their view about UiPath share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that UiPath is a Sell and believe this share price will drop from its current level to $13.00.
-
What Is UiPath's Price Target?
The price target for UiPath over the next 1-year time period is forecast to be $15.73 according to 23 Wall Street analysts, 2 of them rate the stock a Buy, 1 rates the stock a Sell, and 20 analysts rate the stock a Hold.
-
Is PATH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for UiPath is a Hold. 20 of 23 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of PATH?
You can purchase shares of UiPath via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase UiPath shares.
-
What Is The UiPath Share Price Today?
UiPath was last trading at $13.35 per share. This represents the most recent stock quote for UiPath. Yesterday, UiPath closed at $13.81 per share.
-
How To Buy UiPath Stock Online?
In order to purchase UiPath stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
3 High Dividend Dow Jones Stocks
Thanks to surging stock prices over the past two years,…
Will American Tower Stock Recover?
The performance of the real estate investment trust, or REIT,…
Stock Ideas
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
59
Is NVDA Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 125x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
NARI alert for Jan 7
Inari Medical [NARI] is up 22.06% over the past day.
Buy
70
PDEX alert for Jan 7
Pro-Dex [PDEX] is down 10% over the past day.
Buy
52
ALCO alert for Jan 7
Alico [ALCO] is down 1.37% over the past day.
